Title:
NOVEL DELTA OPIOID RECEPTOR LIGANDS
Document Type and Number:
WIPO Patent Application WO2004004715
Kind Code:
A3
Abstract:
A method for the modulation of conditions associated with the delta opioid receptor, which method comprises the administration to the mammal in need thereof an effective or prophylactic amount of a compound of formula (I): wherein X, Y, Z, R1, and R2 are as defined in the specification; to compounds for use in such a method, to processes for their preparation, and to their use in medicine.
Inventors:
DONDIO GIULIO (IT)
MACECCHINI SILVIA (IT)
RAVEGLIA LUCA FRANCESCO (IT)
MACECCHINI SILVIA (IT)
RAVEGLIA LUCA FRANCESCO (IT)
Application Number:
PCT/EP2003/007400
Publication Date:
May 06, 2004
Filing Date:
July 08, 2003
Export Citation:
Assignee:
GLAXOSMITHKLINE SPA (IT)
DONDIO GIULIO (IT)
MACECCHINI SILVIA (IT)
RAVEGLIA LUCA FRANCESCO (IT)
DONDIO GIULIO (IT)
MACECCHINI SILVIA (IT)
RAVEGLIA LUCA FRANCESCO (IT)
International Classes:
A61K31/44; C07D213/74; C07D401/04; C07D401/12; C07D401/14; C07D405/14; (IPC1-7): A61K31/44; A61K31/443; A61K31/444; C07D213/74; C07D401/04; C07D401/12; C07D401/14; C07D405/14
Domestic Patent References:
WO1998014192A1 | 1998-04-09 | |||
WO1998030542A1 | 1998-07-16 | |||
WO1999015508A1 | 1999-04-01 |
Other References:
CANTELLO, BARRIE C. C. ET AL: "[[.omega.-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents", JOURNAL OF MEDICINAL CHEMISTRY (1994), 37(23), 3977-85, XP002261910
Download PDF: